Dedicated software for individualizing Holmium-166 SIRT

SIRT dosimetry made easy

Accurately plan and verify SIRT

Q-suite features pre-treatment planning and post-treatment evaluation of Holmium-166 SIRT.

Guided by an intuitive user interface, Q-suite™ offers one integrated solution, built around QuiremScout® and QuiremSpheres®

Key software features

Treatment planning

– Treatment activity planning as recommended by the IFU of QuiremSpheres®

– Lung dose prediction based on planar and SPECT after QuiremScout® or Tc-99m MAA

– Pre-treatment dose simulation to asses expected dose on healthy liver and tumor of the QuiremSpheres® treatment

Treatment evaluation

– Dose reconstruction based on MR images of QuiremSpheres®

– Dose reconstruction based on SPECT images of QuiremSpheres®

– Evaluate tumor dose and (healthy) liver absorbed dose

Integrated reporting

– Auto-generated reports for dose planning, simulation and dose review

– Manually add comments and screenshots to the report

– Export reports as PDF  to disk or PACS

1. The only dosimetry software solution tailored to treatment planning and evaluation of Holmium-166 Selective Internal Radiation Therapy (SIRT)

2. Dosimetry based on high resolution MR or high accuracy SPECT images

3. Voxel-wise dose calculation based on dose point kernel convolution or local deposition method

4. Measure dose to tissue using registration with anatomical CT or MR datasets

5. Easy to learn; the software has a user-friendly interface displaying only the buttons and tools that you need

Software Requirementsx64 based computer running Microsoft Windows 7, 8.1 or 10
Microsoft .NET version 4.5.2 framework
Hardware recommendationsDual-core CPU, 2.0GHz or higher
SSD with 20 GB free disk space
Regulatory statusCE-marked

Q-SuiteTM is a medical image processing software designed to support planning and verification of holmium-166 SIRT treatment. For planning, Q-SuiteTM determines the required holmium-166 radioactivity needed to deliver a specified radiation dose to the whole liver and determines the expected dose on the lungs, liver and tumor tissue. For verification, Q-SuiteTM reconstructs a 3-dimensional dose distribution based on 3D SPECT-CT images or multi-slice MR images that were acquired during or after administration of the therapeutic holmium-166 microspheres. In combination with anatomical MR or CT images, dose values within tissues of interest can be measured and reported.

Q-SuiteTM is indicated for patients that are eligible for SIRT treatment of liver tumors.

Q-SuiteTM is intended to support planning and evaluation of SIRT treatment with holmium-166 microspheres.

You can download the Q-SuiteTM Instructions for Use on the Product Documentation page.

Are you a healthcare professional?

This webpage can include promotional content regarding one or several products of Quirem Medical, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public.